Floatz logo

11 assets in Bone Sarcoma

Therapeutic assets addressing Bone Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
Bone Sarcoma
Essen BiotechP2BB (64)
Fludarabine
Bone Sarcoma
Essen BiotechP2B (59)
Ipilimumab
Bone Sarcoma
M.D. Anderson Cancer CenterP2CCC (53)
Lifileucel
Bone Sarcoma
M.D. Anderson Cancer CenterP2CCC (53)
Nivolumab
Bone Sarcoma
M.D. Anderson Cancer CenterP2CCC (53)
Teonanacatl
Bone Sarcoma
University Health Network, TorontoP2CCC (53)
cd146/her2 car-t cells
Bone Sarcoma
Essen BiotechP1/2CCC (48)
Cdx 1140
Bone Sarcoma
University of Southern CaliforniaP1CC (43)
Pembrolizumab
Bone Sarcoma
University of Southern CaliforniaP1CC (43)
Recombinant Flt3 Ligand
Bone Sarcoma
University of Southern CaliforniaP1CC (43)
Tocilizumab
Bone Sarcoma
University of Southern CaliforniaP1CC (43)